###begin article-title 0
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human L-threonine 3-dehydrogenase gene is an expressed pseudogene
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 287 288 287 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 326 332 <span type="species:ncbi:10090">murine</span>
###xml 424 429 <span type="species:ncbi:9606">human</span>
L-threonine is an indispensable amino acid. One of the major L-threonine degradation pathways is the conversion of L-threonine via 2-amino-3-ketobutyrate to glycine. L-threonine dehydrogenase (EC 1.1.1.103) is the first enzyme in the pathway and catalyses the reaction: L-threonine + NAD+ = 2-amino-3-ketobutyrate + NADH. The murine and porcine L-threonine dehydrogenase genes (TDH) have been identified previously, but the human gene has not been identified.
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 723 724 723 724 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human TDH gene is located at 8p23-22 and has 8 exons spanning 10 kb that would have been expected to encode a 369 residue ORF. However, 2 cDNA TDH transcripts encode truncated proteins of 157 and 230 residues. These truncated proteins are the result of 3 mutations within the gene. There is a SNP, A to G, present in the genomic DNA sequence of some individuals which results in the loss of the acceptor splice site preceding exon 4. The acceptor splice site preceding exon 6 was lost in all 23 individuals genotyped and there is an in-frame stop codon in exon 6 (CGA to TGA) resulting in arginine-214 being replaced by a stop codon. These truncated proteins would be non-functional since they have lost part of the NAD+ binding motif and the COOH terminal domain that is thought to be involved in binding L-threonine. TDH mRNA was present in all tissues examined.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human L-threonine 3-dehydrogenase gene is an expressed pseudogene having lost the splice acceptor site preceding exon 6 and codon arginine-214 (CGA) is mutated to a stop codon (TGA).
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 214 215 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 319 320 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 488 489 488 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
Liver failure is a cause of considerable mortality; therefore bioartificial livers may offer significant therapeutic benefit. Porcine-derived hepatocytes are being used in clinical studies of bioartificial livers [1,2]. There may, however, be significant differences in the activities of liver enzymes between species [3]. These differences are also important considerations when the pharmaceutical industry conducts new drug metabolism and pharmacokinetic studies on key mammal species [4].
###end p 8
###begin p 9
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
The liver plays a critical role in regulating the circulating concentrations of amino acids. The regulation of amino acid supply to bioartificial organs and maintaining the activity of the amino acid-metabolising enzymes will be important in their development. Active maintenance of the optimal amino acid concentrations will offer the possibility of prolonging the differentiated function of hepatocytes in bioartificial livers [5].
###end p 9
###begin p 10
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 630 632 630 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 634 636 634 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 637 638 637 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 733 735 733 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 737 739 737 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 760 761 760 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 481 486 <span type="species:ncbi:9606">human</span>
L-threonine is one of three indispensable amino acids since mammals do not possess the necessary enzymes for the transamination of threonine [6]. However, the transient apoenzyme form of L-threonine dehydratase bound to pyridoxamine 5'-phosphate dehydratase can carry out a half-transamination of L-threonine [7]. Once L-threonine is oxidised through various catabolic pathways it is lost for the purposes of protein synthesis. Therefore, it is important for determining levels of human nutrition that factors regulating threonine oxidation are identified. The international recommended intake of L-threonine for adults is 7 mg.kg-1.d-1[8]. However, this has recently been challenged as being too low and a recommendation of 15 mg.kg-1.d-1 has been suggested [9].
###end p 10
###begin p 11
###xml 201 202 201 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 202 203 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 444 445 444 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1011 1013 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1014 1016 1014 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
There are two major L-threonine degradation pathways. L-threonine is either catabolised by L-threonine 3-dehydrogenase to 2-amino-3-ketobutyrate or by L-serine/threonine dehydratase (EC 4.2.1.16) to NH4+ and 2-ketobutyrate. In both eukaryotic and prokaryotic cells, the conversion of L-threonine via 2-amino-3-ketobutyrate to glycine takes place in a two-step process [10,11]. L-threonine dehydrogenase catalyses the reaction: L-threonine + NAD+ = 2-amino-3-ketobutyrate + NADH. The subsequent reaction between 2-amino-3-ketobutyrate and coenzyme A to form glycine and acetyl-CoA is catalysed by 2-amino-3-ketobutyrate coenzyme A ligase (EC 2.3.1.29 also called glycine acetyltransferase; gene names KBL and GCAT). L-threonine dehydrogenase and 2-amino-3-ketobutyrate coenzyme A ligase are associated physically on the inner membrane-matrix of mitochondria where the two enzymes form a complex with a stoichiometry of one threonine dehydrogenase tetramer to two 2-amino-3-ketobutyrate coenzyme A ligase dimers [12-14].
###end p 11
###begin p 12
###xml 168 169 168 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 441 446 441 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 525 526 525 526 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 537 539 537 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">13</sup>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 919 920 919 920 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1069 1071 1069 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 232 236 <span type="species:ncbi:9823">pigs</span>
###xml 241 245 <span type="species:ncbi:10116">rats</span>
###xml 341 344 <span type="species:ncbi:10116">rat</span>
###xml 349 352 <span type="species:ncbi:9685">cat</span>
###xml 486 492 <span type="species:ncbi:9606">humans</span>
###xml 794 801 <span type="species:ncbi:9606">infants</span>
###xml 1193 1199 <span type="species:ncbi:9606">humans</span>
In mammals, the removal of the 1-carbon of threonine is thought to occur through threonine dehydrogenase, this carbon being incorporated into glycine and released as CO2 by the mitochondrial glycine cleavage system. In normally-fed pigs and rats 80 to 87% of L-threonine catabolism occurs via threonine dehydrogenase [15,16] and in isolated rat and cat hepatocytes 35% to 50% of threonine oxidation occurs through this pathway [17,18]. Zhao et al. measured threonine oxidation in adult humans by the production of labelled CO2 from L-[1-13C]threonine and concluded that the conversion of threonine to glycine through the threonine dehydrogenase pathway was not important if it exists at all [19]. However, the dehydrogenase pathway is thought to account for 44% of total threonine oxidation in infants [20]. More recently, the same group used a more sensitive method to measure the production of labelled glycine and CO2 in adults and suggested that there was some threonine catabolism via the threonine dehydrogenase pathway, but it accounted for only 7-11% of total [21]. This suggested that the L-serine/threonine dehydratase pathway is the dominant route in the catabolism of threonine in humans.
###end p 12
###begin p 13
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 294 295 294 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 31 37 <span type="species:ncbi:10090">murine</span>
###xml 332 337 <span type="species:ncbi:9606">human</span>
###xml 454 459 <span type="species:ncbi:9606">human</span>
Recently, the sequences of the murine and porcine TDH cDNAs have been reported [22]. The amino-terminal regions of these proteins have characteristics of a mitochondrial targeting sequence and are related to the UDP-galactose 4-epimerases, with both enzyme families having an amino-terminal NAD+ binding domain. The sequence of the human KBL transcript, the second enzyme in the pathway, has also been described [23] and this study aimed to identify the human TDH gene.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human TDH gene
###end title 15
###begin p 16
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 624 626 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 4 10 <span type="species:ncbi:10090">murine</span>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 126 132 <span type="species:ncbi:10090">murine</span>
###xml 169 174 <span type="species:ncbi:9606">human</span>
###xml 222 227 <span type="species:ncbi:9606">human</span>
###xml 533 539 <span type="species:ncbi:10090">murine</span>
###xml 573 578 <span type="species:ncbi:9606">human</span>
The murine L-threonine 3-dehydrogenase gene (TDH) has recently been identified [22]. The human genome was searched using this murine sequence and only a single putative human TDH gene was found to be present. The putative human TDH gene is located on clone RP11-110L10, chromosome 8p23-22 (GenBank accession No. AC011959, Whitehead Institute/MIT Center for Genome Research, USA), between the gene for acyl-malonyl condensing enzyme and hypothetical protein, C8orf13 gene (accession No. XP_088377) (Figure 1A). By comparison with the murine TDH gene and the porcine cDNA, 8 human exons were identified spanning 10 kb (Figure 1B). The predicted start of the ORF is in good sequence context for the initiation of translation [24].
###end p 16
###begin p 17
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 457 462 <span type="species:ncbi:9606">human</span>
Chromosomal localisation and gene structure of the human TDH gene. (A) The human TDH gene is located at 8p23 and the neighbouring genes are: myotubularin related protein 8, MTMR8: acyl-malonyl condensing enzyme, AMAC: threonine dehydrogenase, TDH: hypothetical protein, C8orf13; B lymphoid tyrosine kinase, BLK. Genes encoded by + and - stands are shown above and below the line respectively. The telomeric and centromeric directions are indicated. (B) The human TDH gene spans 10 kb and consists of 8 exons. The putative initiation methionine codon, stop codon and poly-adenylation signal are shown. Closed boxes indicate the ORF and the sizes (in bp) of the exons and introns are indicated.
###end p 17
###begin p 18
###xml 42 43 42 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 151 156 <span type="species:ncbi:9606">human</span>
###xml 264 269 <span type="species:ncbi:9606">human</span>
The sequence of the human TDH exons (Fig. 2) has 84% identity with the porcine cDNA at the nucleotide level in the ORF and the theoretical full-length human protein has 85% identity and 97% similarity with the porcine TDH protein [22], suggesting that this is the human TDH gene. The first potential polyadenylation signal site (ATTAAA) is also conserved between species.
###end p 18
###begin p 19
###xml 292 294 292 294 <bold xmlns:xlink="http://www.w3.org/1999/xlink">AG</bold>
###xml 292 294 292 294 <underline xmlns:xlink="http://www.w3.org/1999/xlink"><bold>AG</bold></underline>
###xml 296 298 296 298 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GT</bold>
###xml 296 298 296 298 <underline xmlns:xlink="http://www.w3.org/1999/xlink"><bold>GT</bold></underline>
###xml 411 417 411 417 <bold xmlns:xlink="http://www.w3.org/1999/xlink">attaaa</bold>
###xml 411 417 411 417 <underline xmlns:xlink="http://www.w3.org/1999/xlink"><bold>attaaa</bold></underline>
###xml 422 423 422 423 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 422 423 422 423 <underline xmlns:xlink="http://www.w3.org/1999/xlink"><bold>c</bold></underline>
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 101 107 <span type="species:ncbi:10090">murine</span>
Sequence and translation of the human TDH exons. A comparison of the human genomic sequence with the murine TDH gene enabled the identification of 8 homologous exons on clone RP11-110L10. A translation of the exons is shown below the nucleotide sequence. The acceptor and donor splice sites (AG &GT) at the ends of each exon are shown in uppercase and underlined. The potential polyadenylation signal and site (attaaa and c) are shown in bold and underlined.
###end p 19
###begin title 20
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human TDH protein
###end title 20
###begin p 21
###xml 447 459 447 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homo sapiens</italic>
###xml 464 480 464 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 580 581 580 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 589 590 589 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 975 976 975 976 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 362 367 <span type="species:ncbi:9606">human</span>
###xml 447 459 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 464 480 <span type="species:ncbi:562">Escherichia coli</span>
The predicted human TDH protein possesses very weak similarity to the human uridine diphosphogalactose-4-epimerase protein (GALE). GALE catalyses the interconversion of UDP-galactose and UDP-glucose in the metabolic pathway that converts galactose into glucose1-phosphate, and also catalyses the interconversion of UDP-GalNAc and UDP-GlcNAc. An alignment of the human TDH protein with other eukaryotic TDH protein sequences and GALE proteins from Homo sapiens and Escherichia coli identified conserved residues likely to contact the nicotinamide-adenine-dinucleotide cofactor (NAD+) (Fig. 3) [25]. They are Gly-58, Gly-61, Gly-64, Asp-84, Asp-102, Ile-103, Leu-104, His-123, Leu-127, Val-142, Asn-143, Ser-165, Tyr-191, Lys-195 and Tyr-218 [26-29]. In view of the different substrates utilised by the 2 enzymes, of those 22 residues that contact the sugar substrate in GALE only one, Asp-325, is conserved (excluding those residues involved in contact with both sugar and NAD+).
###end p 21
###begin p 22
###xml 235 247 235 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homo sapiens</italic>
###xml 320 330 320 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sus scrofa</italic>
###xml 360 372 360 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus</italic>
###xml 402 413 402 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Danio rerio</italic>
###xml 469 486 469 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Takifugu rubripes</italic>
###xml 531 549 531 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis</italic>
###xml 574 597 574 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster</italic>
###xml 637 659 637 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis elegans</italic>
###xml 696 712 696 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 1500 1502 1500 1502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1503 1505 1503 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 235 247 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 320 330 <span type="species:ncbi:9823">Sus scrofa</span>
###xml 333 336 <span type="species:ncbi:9823">pig</span>
###xml 360 372 <span type="species:ncbi:10090">Mus musculus</span>
###xml 374 379 <span type="species:ncbi:10090">mouse</span>
###xml 402 413 <span type="species:ncbi:7955">Danio rerio</span>
###xml 415 424 <span type="species:ncbi:7955">zebrafish</span>
###xml 469 486 <span type="species:ncbi:31033">Takifugu rubripes</span>
###xml 531 549 <span type="species:ncbi:7719">Ciona intestinalis</span>
###xml 574 597 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 637 659 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 696 712 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1079 1084 <span type="species:ncbi:9606">human</span>
Clustal alignment of the predicted human protein with other eukaryotic L-threonine dehydrogenase (TDH) protein sequences and 2 UDP-galactose 4-epimerase sequences (GALE). The species and the derivation of the sequences are as follows: Homo sapiens, HsTDH, genomic DNA (accession No. AC011959); HsGALE, cDNA (NP_000394); Sus scrofa, (pig), Ss, cDNA (AY095535); Mus musculus, mouse, Mm, cDNA (AY116662); Danio rerio (zebrafish), Dr, ESTs (electronic contigous sequence); Takifugu rubripes (puffer fish), Tr, genomic DNA, (AF411956); Ciona intestinalis (a tunicate), Ci, ESTs; Drosophila melanogaster, Dm, genomic DNA gene CG5955 and ESTs; Caenorhabditis elegans, Ce, genomic DNA (U64847) and ESTs; Escherichia coli, EcTDH (P07913) and EcGALE (AAC73846). The locations of the exon/exon boundaries are shown on the translated protein as underlined residues. Conserved residues are indicated by a (*), strongly similar residues by a (:) and weakly similar residues by a (.). Residues that are common to at least two protein sequences are shown in bold. The in-frame stop codon in the human sequence is indicated by a red (#). Gale protein residues in contact with the ligand nicotinamide-adenine-dinucleotide are highlighted in green and those residues in contact with the sugar ligands, uridine-5'-diphosphate-mannose and uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-d-galactose are highlighted in yellow. Those residues that have been shown to contact both NAD and sugar are highlighted in light blue [26-29].
###end p 22
###begin title 23
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human TDH predicted secondary structure
###end title 23
###begin p 24
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 306 313 306 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 327 328 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 430 431 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 847 848 847 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 306 313 <span type="species:ncbi:562">E. coli</span>
###xml 335 340 <span type="species:ncbi:9606">human</span>
Using the translation of the human genomic sequence (with the stop codon replaced with the conserved arginine residue found in other TDH proteins) the predicted secondary structure of the likely "ancestral" TDH protein was determined using Psi-Pred [30] and aligned with the crystal structure of GALE from E. coli[29,31] (Fig. 4). The human ancestral TDH protein would have been a mixed alpha-helices/beta-sheet protein with a NAD+ binding Rossmann-fold and belongs to the tyrosine-dependent oxidoreductase protein family (also known as short-chain dehydrogenases). The characteristic Tyr-x-x-x-Lys couple (residues 191 and 195) found in all family members is important for catalysis with the conserved tyrosine serving as the active-site base [33]. Two domains were identified, with the larger amino-terminus domain (residues 53-234) having a NAD+ binding motif and the smaller carboxy-terminus domain (residues 218-329) likely to be involved in L-threonine binding. It is likely that the substrate is located in the cleft between the two domains.
###end p 24
###begin p 25
###xml 218 234 218 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 397 404 397 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 440 447 440 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 218 234 <span type="species:ncbi:562">Escherichia coli</span>
###xml 273 278 <span type="species:ncbi:9606">human</span>
###xml 346 351 <span type="species:ncbi:9606">human</span>
###xml 397 404 <span type="species:ncbi:562">E. coli</span>
###xml 440 447 <span type="species:ncbi:562">E. coli</span>
Predicted secondary structure of human "ancestral" TDH protein was determined using the Psi-Pred program and was aligned with that of the crystal structure of uridine diphosphogalactose-4-epimerase protein (GALE) from Escherichia coli[29,31] using 3D-PSSM. The labels are: human "ancestral" TDH protein predicted secondary structure, HsTDH_PSSM; human "ancestral" TDH protein sequence, HsTDH_seq; E. coli GALE protein sequence, EcGale_seq; E. coli GALE protein secondary structure, 1udc_SS; alpha-helix, H, highlighted in light blue; beta-sheet, E, highlighted in yellow; c = turn, coil or loop. Identical residues are shown and additionally, a ":" indicates positive equivalence.
###end p 25
###begin title 26
###xml 17 22 <span type="species:ncbi:9606">human</span>
Mutations in the human TDH gene
###end title 26
###begin p 27
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 370 375 <span type="species:ncbi:9606">human</span>
However, there are 3 mutations that disrupt the gene transcription and translation on the sequence of genomic clone RP11-110L10 (Fig. 2). There is a loss of the acceptor splice sites in exon 4 and 6 and an in-frame stop codon in exon 6 (from the expected CGA to TGA) resulting in arginine-214 being replaced by a stop codon. Together, these mutations suggested that the human TDH gene is a pseudogene.
###end p 27
###begin p 28
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 219 236 219 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Takifugu rubripes</italic>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 625 627 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 196 201 <span type="species:ncbi:10090">mouse</span>
###xml 219 236 <span type="species:ncbi:31033">Takifugu rubripes</span>
###xml 258 263 <span type="species:ncbi:9606">human</span>
###xml 486 491 <span type="species:ncbi:9606">human</span>
###xml 587 592 <span type="species:ncbi:10090">mouse</span>
###xml 675 680 <span type="species:ncbi:9606">human</span>
###xml 788 793 <span type="species:ncbi:9606">human</span>
To determine whether these mutations were present in other species, sequence alignments around the acceptor splice sites in exons 4 and 6 were constructed (Fig. 5). The genomic sequences from the mouse and puffer fish (Takifugu rubripes or Fugu) and another human genomic clone (AF131216, Institute of Molecular Biotechnology, Germany) have intact acceptor splice sites in exon 4 suggesting that the loss of this splice site is a single nucleotide polymorphism (SNP) (Fig. 5A). In both human genomic DNA sequences the acceptor splice site in exon 6 is lost, but it is intact in both the mouse and puffer fish sequences (Fig. 5B). Similarly, the stop codon is present in both human genomic DNA sequences, but it is not present in genomic DNA, cDNA and EST sequences from other species. In human genomic DNA sequence (AC011959) there is also an A to T mutation in codon 201 (ATG to TTG, in exon 5) resulting a methionine to leucine substitution.
###end p 28
###begin p 29
###xml 172 174 172 174 <underline xmlns:xlink="http://www.w3.org/1999/xlink">gt</underline>
###xml 179 181 179 181 <underline xmlns:xlink="http://www.w3.org/1999/xlink">ag</underline>
###xml 278 279 278 279 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 278 280 278 280 <underline xmlns:xlink="http://www.w3.org/1999/xlink"><bold>g</bold>g</underline>
###xml 407 419 407 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homo sapiens</italic>
###xml 471 483 471 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus</italic>
###xml 566 583 566 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Takifugu rubripes</italic>
###xml 645 648 645 648 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TGA</bold>
###xml 767 769 767 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ag</italic>
###xml 767 769 767 769 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ag</italic></bold>
###xml 767 769 767 769 <underline xmlns:xlink="http://www.w3.org/1999/xlink"><bold><italic>ag</italic></bold></underline>
###xml 879 882 879 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGA</italic>
###xml 879 882 879 882 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>TGA</italic></bold>
###xml 879 882 879 882 <underline xmlns:xlink="http://www.w3.org/1999/xlink"><bold><italic>TGA</italic></bold></underline>
###xml 945 955 945 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sus scrofa</italic>
###xml 1008 1025 1008 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rattus norvegicus</italic>
###xml 1058 1071 1058 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gallus gallus</italic>
###xml 1116 1135 1116 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Silurana tropicalis</italic>
###xml 1170 1181 1170 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Danio rerio</italic>
###xml 1209 1227 1209 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis</italic>
###xml 1252 1275 1252 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster</italic>
###xml 1314 1336 1314 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis elegans</italic>
###xml 1368 1386 1368 1386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trypanosoma brucei</italic>
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 253 258 <span type="species:ncbi:9606">human</span>
###xml 407 419 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 471 483 <span type="species:ncbi:10090">Mus musculus</span>
###xml 566 583 <span type="species:ncbi:31033">Takifugu rubripes</span>
###xml 709 714 <span type="species:ncbi:9606">human</span>
###xml 940 943 <span type="species:ncbi:9823">pig</span>
###xml 945 955 <span type="species:ncbi:9823">Sus scrofa</span>
###xml 1003 1006 <span type="species:ncbi:10116">rat</span>
###xml 1008 1025 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 1049 1056 <span type="species:ncbi:9031">chicken</span>
###xml 1058 1071 <span type="species:ncbi:9031">Gallus gallus</span>
###xml 1095 1114 <span type="species:ncbi:8364">western clawed frog</span>
###xml 1116 1135 <span type="species:ncbi:8364">Silurana tropicalis</span>
###xml 1159 1168 <span type="species:ncbi:7955">zebrafish</span>
###xml 1170 1181 <span type="species:ncbi:7955">Danio rerio</span>
###xml 1209 1227 <span type="species:ncbi:7719">Ciona intestinalis</span>
###xml 1241 1250 <span type="species:ncbi:7227">fruit fly</span>
###xml 1252 1275 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 1314 1336 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 1368 1386 <span type="species:ncbi:5691">Trypanosoma brucei</span>
Comparison of the human TDH gene sequences in the region of exon 4 and 6 acceptor sites with those of other species. (A) The splice donor and acceptor sites are indicated (gt and ag respectively). There is a splice site mutation in exon 4 in one of the human genomic sequences (gg, coloured red). The translations of the genes are shown below the DNA sequences (ORF). The species and accession numbers are: Homo sapiens, HsTDH_gDNA_A (AF131216); HsTDH_gDNA_B (AC011959); Mus musculus, MmTDHgDNA (14.54000001-55000000 supercontig, Sanger Centre, UK) and puffer fish, Takifugu rubripes, TrTDH_gDNA (AF411956). (B) There is an in-frame stop codon (TGA, coloured blue) and a splice site mutation in exon 6 in the human genomic sequence (AF131216). A cryptic splice site (ag, coloured red) was utilised in cDNA clone 1 that altered the reading frame, resulting in another stop codon (TGA, coloured green). The species and accession numbers are: pig, Sus scrofa, SsTDH_cDNA (AY095535); MmTDH_cDNA (AY116662); rat, Rattus norvegicus, RmTDH_EST (BF557448); chicken, Gallus gallus, GgTDH_EST (BM491791); western clawed frog, Silurana tropicalis, StTDH_EST (AL638064); zebrafish, Danio rerio, DrTDH_ESTs; the tunicate, Ciona intestinalis, CiTDH_ESTs; fruit fly, Drosophila melanogaster, DmTDH_gDNA (AAF51607); the nematode, Caenorhabditis elegans, CeTDH_ESTs and the euglenoid, Trypanosoma brucei, TbTDH_gDNA (AC084047). There are no introns in this region of the fly, nematode and trypanosome genes (__). Identical nucleotides and residues are shown by *, strongly similar residues by: and weakly similar residues by (.).
###end p 29
###begin title 30
Genotyping of individuals by restriction enzyme digests and DNA sequencing
###end title 30
###begin p 31
###xml 400 403 400 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aci</italic>
###xml 471 473 471 473 <underline xmlns:xlink="http://www.w3.org/1999/xlink">AG</underline>
###xml 686 687 686 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 159 164 <span type="species:ncbi:9606">human</span>
To determine whether these mutations in the 2 human genomic sequences were sequencing errors or just present in those individuals utilised for determining the human genome, the region encompassing the mutations was amplified by PCR from a number of individuals, sequenced and digested with restriction enzymes. Amplicons from the exon 4 splice acceptor site were digested with the restriction enzyme AciI. If the acceptor splice site was not present (G CGG rather than GCAG, acceptor splice site underlined) the 158 bp amplicon was digested to produce restriction fragments of 104 and 54 bp. The restriction enzyme digest pattern and DNA sequence of 3 individuals are illustrated (Fig. 6) in which one individual has the splice site intact, another has lost the splice site and the third has the heterozygous condition. Digestion is not as complete as would be expected in the heterozygous condition, presumably due to heteroduplex formation during the PCR. This SNP was found in 20 out of 40 chromosomes examined.
###end p 31
###begin p 32
###xml 134 137 134 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aci</italic>
###xml 357 360 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aci</italic>
Amplicons from individuals with different genotypes for the exon 4 splice acceptor site SNP were digested with the restriction enzyme AciI (upper panel) and DNA sequenced (lower panel). Undigested samples, UD and digested samples, D. Arrows indicate the polymorphic nucleotide. In an individual homozygous for the splice acceptor site (AG, middle panel) no AciI digest site is present. In an individual homozygous for loss of the splice acceptor site (GG, right panel) the 158 bp amplicon is cut into fragments of 104 and 54 bp. In an individual heterozygous for the AG splice acceptor site (RG, left panel) both alleles are present and the amplicon is only partially digested.
###end p 32
###begin p 33
###xml 108 111 108 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hsp</italic>
###xml 184 186 184 186 <underline xmlns:xlink="http://www.w3.org/1999/xlink">Ag</underline>
###xml 330 331 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
Amplicons from the exon 6 splice acceptor site from 3 individuals were digested with the restriction enzyme Hsp92II. If the acceptor splice site was not present (CATG g rather than CATAg) the 207 bp amplicon was digested to produce restriction fragments of 112 and 95 bp. Three individuals examined had lost the splice site (Fig. 7). DNA sequencing verified the loss of the splice site and the presence of the in-frame stop codon in exon 6 in all 20 individuals examined (data not shown).
###end p 33
###begin p 34
###xml 107 110 107 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hsp</italic>
Amplicons from 3 individuals for the exon 6 splice acceptor site were digested with the restriction enzyme Hsp92II. All amplicons were digested showing loss of the splice site. Undigested samples, UD and digested samples, D.
###end p 34
###begin title 35
###xml 26 31 <span type="species:ncbi:9606">human</span>
Copy DNA sequences of the human TDH gene
###end title 35
###begin p 36
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 938 939 938 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 658 663 <span type="species:ncbi:9606">human</span>
The human TDH gene is expressed. PCR amplification from cDNA libraries using primers designed to amplify the TDH ORF was carried out and amplicons of approximately 1000 bp were obtained from cDNAs from 2 individuals, cloned and sequenced. The 1019 bp sequence of clone 1 (AY101186) skipped exon 6, resulting in a premature stop codon in exon 7, (Fig. 8A) and would encode a 230 residue ORF (Fig. 8B). The 935 bp sequence of clone 2 (AY101187) skipped exon 4 and utilised a cryptic splice site in exon 6, 24 bp downstream of the expected site (Fig 5B), resulting in a premature stop codon in exon 6 (Fig. 8A) and would encode a 157 residue ORF (Fig. 8B). The human TDH gene is therefore a pseudogene since all individuals examined contain at least 2 mutations that on translation would generate truncated proteins that would be non-functional since they would be unable to make appropriate contacts with the substrates, L-threonine and NAD+.
###end p 36
###begin p 37
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human TDH pseudogene is expressed. (A) Clones from 2 individuals were sequenced and mapped to the TDH gene. Clone 1 skipped exon 6, and the resulting frame-shift generated a premature stop codon in exon 7 (TGA). Clone 2 skipped exon 4 and utilised a cryptic splice site in exon 6, and the resulting frame-shift generated a premature stop codon in exon 6. (B) The translation of clone 1 (exon 6 skipped) encoded a truncated 230 residue ORF. The skipped exon 4 in clone 2 does not alter the reading frame. However, the use of a cryptic splice site in exon 6, results in a premature stop codon in exon 6. Stop codons are indicated by *.
###end p 37
###begin title 38
###xml 36 41 <span type="species:ncbi:9606">human</span>
Expression of the TDH pseudogene in human tissue and cell types
###end title 38
###begin p 39
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
Reverse-transcriptase PCR was used to determine the presence of the TDH pseudogene mRNA in different tissues and cell types. TDH expression was found in all tissues examined (Fig. 9A). TDH mRNA was present in most cell types examined, but was below the level of detection in endothelial cells, glioma cell lines and some leukaemia cell lines (Fig. 9B). Together, this suggests that the TDH promoter is still active and is regulated in different cell types.
###end p 39
###begin p 40
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 106 111 <span type="species:ncbi:9606">human</span>
###xml 395 400 <span type="species:ncbi:9606">human</span>
Expression of the TDH pseudogene in human tissues and cell types. (A) Expression of the TDH pseudogene in human tissues. The lanes are: 100 bp marker, m; heart, H; brain, B; placenta, Pl; lung, Lu; liver, L; skeletal muscle, M; kidney, K; pancreas, Pa; spleen, S; thymus; Th; prostate, Pr; testis, Te; ovary, O; small intestine, I; negative control, (-). (B) Expression of the TDH pseudogene in human cells. RT-PCR for TDH (top panel) and beta-actin (bottom panel). The cell types examined were: foetal osteoblast, fO; adult osteoblasts, aO; pulmonary foetal fibroblast, HFL-1, fF; adult fibroblasts, aF; placental microvascular endothelial, mE; umbilical vein endothelial, uE; alveolar epithelial adenocarcinoma, A549, EA; bronchial epithelial adenocarcinoma, H322, EH; bronchial smooth muscle, SM; colorectal adenocarcinoma, CaCo2, CE; Epstein-Barr-transformed lymphocyte Ly; erythroleukaemia, K562, EK; erythroleukaemia TF1, ET; glioma, U87, G8; glioma, U373, G3; and negative control (-).
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 152 157 <span type="species:ncbi:9606">human</span>
###xml 248 253 <span type="species:ncbi:9606">human</span>
###xml 255 260 <span type="species:ncbi:10090">mouse</span>
###xml 494 499 <span type="species:ncbi:9606">human</span>
###xml 615 620 <span type="species:ncbi:9606">human</span>
A search of the human genomic sequences for the TDH gene identified only one candidate location on chromosome 8p23-22. This is the expected site of the human TDH gene since there are a number of genes that neighbour the TDH genes in the genomes of human, mouse and puffer fish that are found in common in this locus. They are the myotubularin related protein 8, the B-lymphoid tyrosine kinase and the hypothetical protein C8orf13. There are differences in the gene order and orientation in the human and puffer fish TDH loci indicating that there have been re-arrangements in this locus since the divergence of the human and puffer fish lineages [34].
###end p 42
###begin p 43
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 231 236 <span type="species:ncbi:9606">human</span>
###xml 346 351 <span type="species:ncbi:9606">human</span>
###xml 411 416 <span type="species:ncbi:9606">human</span>
###xml 537 542 <span type="species:ncbi:10090">mouse</span>
###xml 719 724 <span type="species:ncbi:9606">human</span>
The human TDH gene contains 3 mutations that disrupt the gene transcription and translation. There is a loss of the acceptor splice sites preceding exons 4 and 6 and an in-frame stop codon in exon 6. A database search of expressed human sequences identified other TDH cDNAs and ESTs similar to the 2 cDNA sequences described. The sequence of the human cerebellum full-length cDNA clone FLJ25033 (AK057762, NEDO human cDNA sequencing project University of Tokyo, Japan) has 2 5'UTR exons, the first of which corresponds to exon -1 on the mouse genomic DNA sequence [22]. This clone skips both exons 4 and 6, and includes the polyadenylation site. The ORF would encode a truncated 180 residue protein. Three very similar human ESTs (AI005002, AI243637 and AI809781) have exon 4 skipped and use the cryptic acceptor splice site in exon 6 that was found in clone 2 and possesses the in-frame stop codon.
###end p 43
###begin p 44
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 662 664 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 816 817 816 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 900 902 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 903 905 903 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 991 992 991 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1191 1193 1191 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 207 210 <span type="species:ncbi:9823">pig</span>
###xml 215 220 <span type="species:ncbi:10090">mouse</span>
###xml 288 294 <span type="species:ncbi:9606">humans</span>
###xml 361 366 <span type="species:ncbi:9606">human</span>
###xml 671 676 <span type="species:ncbi:9606">human</span>
###xml 1102 1107 <span type="species:ncbi:9606">human</span>
The human TDH gene is a pseudogene because in all individuals examined the gene contains 1 or more mutations that disrupt RNA splicing which give rise to a variety of mRNAs in different individuals. In both pig and mouse TDH cDNAs there was no evidence of alternatively splicing [22]. In humans, arginine-214 is replaced by a stop codon. On translation all the human mRNAs would generate a variety of truncated proteins ranging from 157 to 230 residues, some of which would also contain deletions of residues 96-146; whereas the size of the core of TDH enzyme (residues 48-364) differs by only 2 residues in other species, including some bacterial TDH proteins [22]. The human truncated proteins would be non-functional since they would be unable to make appropriate contacts with the substrates, L-threonine and NAD+. They have lost most of the carboxy-terminal domain, which by homology with GALE [26-29], would be expected to bind L-threonine and also have lost various regions of the NAD+ binding motif that extends from exon 1 to exon 6. In comparison, even single point missense mutations in the human GALE gene disrupt protein function resulting in epimerase-deficiency galactosemia [35].
###end p 44
###begin p 45
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 746 751 746 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 814 815 814 815 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 997 999 997 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1025 1030 1025 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1113 1114 1113 1114 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1253 1255 1253 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1494 1496 1494 1496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1497 1499 1497 1499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1767 1769 1767 1769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1876 1878 1876 1878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 293 299 <span type="species:ncbi:9606">humans</span>
###xml 479 485 <span type="species:ncbi:9606">humans</span>
###xml 704 710 <span type="species:ncbi:9606">humans</span>
###xml 825 831 <span type="species:ncbi:9606">humans</span>
###xml 1323 1328 <span type="species:ncbi:9606">human</span>
###xml 1408 1412 <span type="species:ncbi:9823">pigs</span>
###xml 1417 1421 <span type="species:ncbi:10116">rats</span>
###xml 1543 1549 <span type="species:ncbi:9606">humans</span>
At present, no known human genetic disease has been associated with defects in the threonine dehydrogenase and 2-amino-3-ketobutyrate coenzyme A ligase biochemical pathway. This may be because the enzymatic activity of L-serine/threonine dehydratase is sufficient to metabolise L-threonine in humans. The mitochondrial threonine dehydrogenase enzyme is thought to act in the maintenance of free somatic threonine concentration derived from dietary threonine [15] suggesting that humans may not be able to regulate the level of circulating threonine as well as other mammals. In vertebrates, L-threonine is degraded by two major enzymatic pathways and attempts to determine their relative contribution in humans has been by indirect methods. Zhao et al. measured threonine oxidation by the production of labelled CO2 in adult humans from labelled threonine and concluded that the conversion of threonine to glycine through the threonine dehydrogenase pathway was not important if it exists at all [19]. More recently, Darling et al. used a more sensitive method to measure the production of labelled glycine and CO2 and suggested that there was some threonine catabolism via the threonine dehydrogenase pathway, but it accounted for only 7-11% of total [21]. Direct demonstration of the absence of TDH enzymatic activity in human tissues such as liver remains to be demonstrated. In contrast, in normally-fed pigs and rats 80 to 87% of L-threonine catabolism occurs via threonine dehydrogenase [15,16]. Since the TDH gene is not functioning in humans, what enzyme(s) could be responsible for the small percentage of threonine catabolism to glycine? In bacteria, threonine aldolase also yields glycine, but mammals are thought to lack the "genuine" threonine aldolase [36]. However, serine hydroxymethyltransferase exhibits a low threonine aldolase activity in mammalian liver [36].
###end p 45
###begin p 46
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1270 1272 1270 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 179 184 <span type="species:ncbi:9606">human</span>
###xml 310 316 <span type="species:ncbi:9606">humans</span>
###xml 495 498 <span type="species:ncbi:9606">man</span>
###xml 1298 1303 <span type="species:ncbi:9606">human</span>
Whether the first dehabilitating mutation was the loss of the splice acceptor site preceding exon 6 or the arginine-214 to stop codon mutation is unknown, nor is it known when in human evolution that a functional TDH gene was lost. However, the arginine codon CGA is used in only 11.1% of arginine residues in humans, being prone to mutate to a stop codon. The TDH gene has been conserved throughout evolution, being found in bacteria and other mammals [22], so why has it not been conserved in man? How could such a mutation establish its self in the ancestral population? It is likely that the mutation must have conferred some selectable advantage, under the prevailing environmental conditions, on those individuals who carried it, and arose at a time when the ancestral population was small. Under conditions of protein starvation, threonine dietary intake could have been a limiting factor on growth, survival and successful reproduction and a reduction in the rate of threonine catabolism would have conferred a selective advantage on those individuals with defective TDH gene. Additionally, if we consider that the threonine catabolism pathway is also a glycine synthesis pathway, then a reduction in the production of glycine in inhibitory glycinergic neurons [37] may have contributed to human neural evolution.
###end p 46
###begin p 47
###xml 304 322 304 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trypanosoma brucei</italic>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 6 12 <span type="species:ncbi:9606">humans</span>
###xml 67 72 <span type="species:ncbi:9606">human</span>
###xml 304 322 <span type="species:ncbi:5691">Trypanosoma brucei</span>
Since humans lack a functioning threonine dehydrogenase enzyme and human parasites such as trypanosomes do possess one (Edgar and Horn, unpublished results, GenBank AF529241), the parasite threonine dehydrogenase enzyme is a potential target for therapeutic intervention. Indeed, in trypanosomes such as Trypanosoma brucei, which causes sleeping sickness, L-threonine dehydrogenase is an important metabolic enzyme and inhibition of this enzyme by a wide range of sulphydryl reagents, such as tetraethylthiuram disulphide, leads to a loss of trypanosome viability [38-40].
###end p 47
###begin p 48
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 628 629 628 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 677 679 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 846 847 846 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 873 874 873 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1154 1155 1154 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 47 50 <span type="species:ncbi:9606">man</span>
###xml 86 89 <span type="species:ncbi:9606">Man</span>
###xml 264 267 <span type="species:ncbi:9606">Man</span>
###xml 455 458 <span type="species:ncbi:9606">man</span>
###xml 532 538 <span type="species:ncbi:9606">Humans</span>
###xml 1256 1262 <span type="species:ncbi:9606">humans</span>
Loss of other metabolically important genes in man results in disease susceptibility. Man and primates are scurvy-prone, having lost the L-gulono-gamma-lactone oxidase gene that is found in most other eukaryotes, and are unable to synthesize L-ascorbic acid [41]. Man and primates have also lost the urate oxidase enzyme that catalyses the conversion of uric acid to allantoin. This results in a high concentration of uric acid in the blood, predisposing man to hyperuricemia that can lead to gouty arthritis and renal stones [42]. Humans have recently lost 2 functional genes involved in sialic acid function. They are the CMP-N-acetylneuraminic acid hydroxylase gene (CMAH) [43] and the siglec-like molecule (Siglec-L1) [44]. However, no diseases have yet been associated with the loss of these genes. The CMAH enzyme converts the sialic acid, N-acetylneuraminic acid to N-glycolylneuraminic acid, potentially affecting recognition by a variety of endogenous and exogenous sialic acid-binding lectins. Siglecs are immunoglobulin superfamily member lectins that selectively recognize different sialic acids types and siglec-L1 preferentially recognizes N-glycolylneuraminic acid. To date, no disease has been associated with the loss of the TDH gene, but humans may not be able to metabolise high protein diets as efficiently as other mammals.
###end p 48
###begin title 49
Conclusions
###end title 49
###begin p 50
###xml 184 185 184 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 145 151 <span type="species:ncbi:9606">humans</span>
###xml 329 335 <span type="species:ncbi:9606">humans</span>
###xml 405 409 <span type="species:ncbi:9823">pigs</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 435 438 <span type="species:ncbi:9606">man</span>
The human L-threonine 3-dehydrogenase gene is an expressed pseudogene, which accounts for the very low levels of threonine oxidation measured in humans by the production of labelled CO2 from labelled threonine. This suggests that the L-serine/threonine dehydratase pathway may be the only route in the catabolism of threonine in humans. The presence of a functional TDH gene in key mammal species such as pigs and mice and its loss in man should be taken into consideration when utilising hepatocytes in bioartificial livers and pharmacokinetic studies.
###end p 50
###begin title 51
Methods
###end title 51
###begin title 52
Genotyping of genomic DNA from individuals by restriction enzyme digests and DNA sequencing
###end title 52
###begin p 53
###xml 54 56 54 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 635 638 623 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aci</italic>
###xml 730 733 718 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hsp</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human genomic DNA was isolated from peripheral blood [45]. Regions of genomic DNA surrounding exon 4 and 6 splice acceptor sites were amplified by PCR using primers ATTGCGTGGCTACCAGTGA and CGATCTCCCGAAGATTCTTGT for exon 4 and GAATGAGATTTCAGAAAAAGGCAGG and AACCAGTTGTTCCTCCTCCA for exon 6, using the Advantage 2 cDNA polymerase mix (BD-Clontech, UK). Amplification conditions were: 30 cycles of 94degreesC for 10 sec and 57degreesC for 10 sec. PCR products were desalted using the QIAquick PCR purification kit (Qiagen, UK). Amplicons from the exon 4 splice acceptor site were digested in appropriate buffer with the restriction enzyme AciI. Amplicons from the exon 6 splice acceptor site were digested with the restriction enzyme Hsp92II. The amplicons were also sequenced directly using the big dye terminator cycle sequencing ready reaction kit and AmpliTaq DNA polymerase FS and run on an ABI 377 automated DNA sequencers (both from PE Applied Biosystems, UK).
###end p 53
###begin title 54
###xml 21 26 <span type="species:ncbi:9606">human</span>
Molecular cloning of human L-threonine dehydrogenase cDNAs
###end title 54
###begin p 55
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 204 209 <span type="species:ncbi:9606">human</span>
Clones encoding the human L-threonine dehydrogenase cDNA sequence were obtained by touchdown PCR amplification from liver and lung cDNA libraries using primers derived from regions of the sequence of the human genomic DNA clone RP11-110L10 which had homology to the 5' and 3' ends of the ORF of the porcine TDH cDNA sequence. The primers were: ATGCTGTTCATTAGGATGCTGA and GTTGGCTTGGGCAACTCTG and the cycling conditions were 94degreesC for 10 sec, 64degreesC for 10 sec and 72degreesC for 1 min less -1.0degreesC per cycle for 8 cycles followed by 24 cycles with an annealing temperature of 56degreesC. PCR products were examined by agarose gel electrophoresis and stained with ethidium bromide. For cloning, PCR products were excised from low-melting point agarose gels and the agarose digested with agarase (Promega, UK). The PCR products were cloned into the T-A vector pCR4-TOPO (Invitrogen, The Netherlands) and sequenced in both directions.
###end p 55
###begin title 56
Tissue and cellular distribution of L-threonine dehydrogenase mRNA by RT-PCR
###end title 56
###begin p 57
###xml 194 195 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1076 1078 1069 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 597 600 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
Human cDNA from 14 tissues (BD-Clontech) was analysed for the relative expression of TDH and the housekeeping gene, beta-actin. Approximately, 0.2 ng of oligo-dT primed cDNA (derived from poly A+ RNA) from each tissue was amplified by PCR using Taq Gold polymerase (AB Applied Biosystems). For the analysis of TDH expression in 15 cultured cell isolates and cell lines, total RNA was extracted using guanidine thiocyanate and treated with DNase-I to remove any contaminating genomic DNA (total RNA isolation system, Promega). Total RNA was reverse transcribed with random hexamer primers using an AMV RNase H- reverse transcriptase, ThermoScript (Invitrogen). Approximately, cDNA derived from 50 ng of total RNA was used in each PCR. Tissue and cell master mixes were divided into gene specific mixes with the addition of PCR primers to a final concentration of 200 muM. The L-threonine dehydrogenase primers were: exon 7 and 8 boundary, GCCAGGCCATAGCGGAT and exon 8, TGTTTCCACCCCCAGTCCTT and produced a 73 bp amplicon and the beta-actin primers were as previously described [46] and produced a 208 bp amplicon. The amplification conditions were; a 10 min hot start to activate the polymerase followed by 40 cycles of 95degreesC for 15 sec and 60degreesC for 1 min. The amplicons were examined by ethidium bromide stained agarose gel electrophoresis.
###end p 57
###begin title 58
Acknowledgements
###end title 58
###begin p 59
I thank Athina Milona for assistance with the genotyping and the Advanced Biotechnology Centre for DNA sequencing (Charing Cross Campus, Imperial College).
###end p 59
###begin article-title 60
A bioartificial liver - state of the art.
###end article-title 60
###begin article-title 61
Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems.
###end article-title 61
###begin article-title 62
Intra- and interspecific variation in primate gene expression patterns.
###end article-title 62
###begin article-title 63
A commentary on the use of hepatocytes in drug metabolism studies during drug discovery and development.
###end article-title 63
###begin article-title 64
The simulated microgravity environment maintains key metabolic functions and promotes aggregation of primary porcine hepatocytes.
###end article-title 64
###begin article-title 65
###xml 94 99 <span type="species:ncbi:9940">sheep</span>
Does glutamine act as a substrate for transamination reactions in the liver of fed and fasted sheep?
###end article-title 65
###begin article-title 66
###xml 15 18 <span type="species:ncbi:10116">rat</span>
Restoration of rat liver L-threonine dehydratase activity by pyridoxamine 5'-phosphate: the half-transaminating activity of L-threonine dehydratase and its regulatory role.
###end article-title 66
###begin article-title 67
Energy and protein requirements. Report of a Joint FAO/WHO/UNU Expert Consultation.
###end article-title 67
###begin article-title 68
Threonine requirement of healthy adults, derived with a 24-h indicator amino acid balance technique.
###end article-title 68
###begin article-title 69
Catabolism of threonine in mammals by coupling of L-threonine 3-dehydrogenase with 2-amino-3-oxobutyrate-CoA ligase.
###end article-title 69
###begin article-title 70
###xml 86 102 86 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 86 107 <span type="species:ncbi:83333">Escherichia coli K-12</span>
L-threonine dehydrogenase. Purification and properties of the homogeneous enzyme from Escherichia coli K-12.
###end article-title 70
###begin article-title 71
###xml 29 36 <span type="species:ncbi:9031">chicken</span>
L-Threonine dehydrogenase of chicken liver. Purification, characterization, and physiological significance.
###end article-title 71
###begin article-title 72
Mitochondrial L-threonine dehydrogenase.
###end article-title 72
###begin article-title 73
Interaction between L-threonine dehydrogenase and aminoacetone synthetase and mechanism of aminoacetone production.
###end article-title 73
###begin article-title 74
###xml 58 61 <span type="species:ncbi:10116">rat</span>
Metabolic homoeostasis of L-threonine in the normally-fed rat. Importance of liver threonine dehydrogenase activity.
###end article-title 74
###begin article-title 75
###xml 49 53 <span type="species:ncbi:9823">pigs</span>
Quantitative partition of threonine oxidation in pigs: effect of dietary threonine.
###end article-title 75
###begin article-title 76
###xml 33 36 <span type="species:ncbi:10116">rat</span>
Threonine metabolism in isolated rat hepatocytes.
###end article-title 76
###begin article-title 77
###xml 117 132 117 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Felis domestica</italic>
###xml 102 115 <span type="species:ncbi:9685">domestic cats</span>
Threonine is catabolized by L-threonine 3-dehydrogenase and threonine dehydratase in hepatocytes from domestic cats (Felis domestica).
###end article-title 77
###begin article-title 78
###xml 56 59 <span type="species:ncbi:9606">men</span>
Threonine kinetics at graded threonine intakes in young men.
###end article-title 78
###begin article-title 79
###xml 30 37 <span type="species:ncbi:9606">infants</span>
Threonine kinetics in preterm infants fed their mothers' milk or formula with various ratios of whey to casein.
###end article-title 79
###begin article-title 80
###xml 88 94 <span type="species:ncbi:9606">humans</span>
Threonine dehydrogenase is a minor degradative pathway of threonine catabolism in adult humans.
###end article-title 80
###begin article-title 81
Molecular cloning and tissue distribution of mammalian L-threonine 3-dehydrogenases.
###end article-title 81
###begin article-title 82
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 35 41 <span type="species:ncbi:10090">murine</span>
Molecular cloning of the human and murine 2-amino-3-ketobutyrate coenzyme A ligase cDNAs.
###end article-title 82
###begin article-title 83
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.
###end article-title 83
###begin article-title 84
Automated analysis of interatomic contacts in proteins.
###end article-title 84
###begin article-title 85
###xml 75 91 75 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 75 91 <span type="species:ncbi:562">Escherichia coli</span>
Structural analysis of UDP-sugar binding to UDP-galactose 4-epimerase from Escherichia coli.
###end article-title 85
###begin article-title 86
###xml 103 119 103 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 103 119 <span type="species:ncbi:562">Escherichia coli</span>
Dramatic differences in the binding of UDP-galactose and UDP-glucose to UDP-galactose 4-epimerase from Escherichia coli.
###end article-title 86
###begin article-title 87
###xml 54 55 54 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human UDP-galactose 4-epimerase. Accommodation of UDP-N-acetylglucosamine within the active site.
###end article-title 87
###begin article-title 88
###xml 43 59 43 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 43 59 <span type="species:ncbi:562">Escherichia coli</span>
###xml 103 106 <span type="species:ncbi:9615">dog</span>
Structural analysis of the Y299C mutant of Escherichia coli UDP-galactose 4-epimerase. Teaching an old dog new tricks.
###end article-title 88
###begin article-title 89
Protein secondary structure prediction based on position-specific scoring matrices.
###end article-title 89
###begin article-title 90
###xml 58 74 58 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 58 74 <span type="species:ncbi:562">Escherichia coli</span>
The molecular structure of UDP-galactose 4-epimerase from Escherichia coli determined at 2.5 A resolution.
###end article-title 90
###begin article-title 91
Enhanced Genome Annotation using Structural Profiles in the Program 3D-PSSM.
###end article-title 91
###begin article-title 92
###xml 77 82 <span type="species:ncbi:9606">human</span>
Crystallographic evidence for Tyr 157 functioning as the active site base in human UDP-galactose 4-epimerase.
###end article-title 92
###begin article-title 93
Conserved regulation of the lymphocyte-specific expression of lck in the Fugu and mammals.
###end article-title 93
###begin article-title 94
###xml 58 63 <span type="species:ncbi:9606">human</span>
Identification and characterization of a mutation, in the human UDP-galactose-4-epimerase gene, associated with generalized epimerase-deficiency galactosemia.
###end article-title 94
###begin article-title 95
Serine hydroxymethyltransferase and threonine aldolase: are they identical?
###end article-title 95
###begin article-title 96
The glycinergic inhibitory synapse.
###end article-title 96
###begin article-title 97
###xml 30 48 30 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trypanosoma brucei</italic>
###xml 30 48 <span type="species:ncbi:5691">Trypanosoma brucei</span>
Utilization of amino acids by Trypanosoma brucei in culture: L-threonine as a precursor for acetate.
###end article-title 97
###begin article-title 98
###xml 24 42 24 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trypanosoma brucei</italic>
###xml 24 42 <span type="species:ncbi:5691">Trypanosoma brucei</span>
Threonine catabolism in Trypanosoma brucei .
###end article-title 98
###begin article-title 99
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trypanosoma</italic>
###xml 13 27 13 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Schizotrypanum</italic>
###xml 29 37 29 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dionisii</italic>
Trypanosoma (Schizotrypanum) dionisii as a model for chemotherapeutic studies related to Chagas's disease.
###end article-title 99
###begin article-title 100
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 155 158 <span type="species:ncbi:9606">man</span>
Cloning and chromosomal mapping of the human nonfunctional gene for L-gulono-gamma-lactone oxidase, the enzyme for L-ascorbic acid biosynthesis missing in man.
###end article-title 100
###begin article-title 101
Urate oxidase: primary structure and evolutionary implications.
###end article-title 101
###begin article-title 102
###xml 14 19 <span type="species:ncbi:9606">human</span>
A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence.
###end article-title 102
###begin article-title 103
###xml 18 23 <span type="species:ncbi:9606">human</span>
A second uniquely human mutation affecting sialic acid biology.
###end article-title 103
###begin article-title 104
A rapid procedure for extracting genomic DNA from leukocytes.
###end article-title 104
###begin article-title 105
Analysis of gene expression in single oocytes and embryos by real-time rapid cycle fluorescence monitored RT-PCR.
###end article-title 105

